Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

New Line of PCR Workstations Provide Contamination-Free Zones on the Bench

By BiotechDaily International staff writers
Posted on 26 Aug 2013
Image: Mystaire Misonix MY-PCR Prep Stations are compact laminar flow enclosures that reduce the risk of sample contamination while performing polymerase chain reaction (PCR) experiments (Photo courtesy of Mystaire Misonix).
Image: Mystaire Misonix MY-PCR Prep Stations are compact laminar flow enclosures that reduce the risk of sample contamination while performing polymerase chain reaction (PCR) experiments (Photo courtesy of Mystaire Misonix).
Image: My-PCR Workstation - how it works: Laboratory air is pulled into MY-PCR workstation at “A” and then forced through the HEPA filter at “B.” Smooth and even Class 100 laminar flow air enters the work area at “C” and then exits the workstation at “D” (Photo courtesy of Mystaire Misonix).
Image: My-PCR Workstation - how it works: Laboratory air is pulled into MY-PCR workstation at “A” and then forced through the HEPA filter at “B.” Smooth and even Class 100 laminar flow air enters the work area at “C” and then exits the workstation at “D” (Photo courtesy of Mystaire Misonix).
A timely new product for biotech laboratories provides molecular biology investigators with a “personal cleanroom” for use while performing PCR preparations prior to the amplification of DNA and RNA.

Products in the new line of MY‑PCR Prep Stations manufactured by Mystaire Misonix (Creedmoor, NC, USA) establish bench-top personal clean zones that enable the investigator to amplify RNA and DNA while minimizing the potential for background from airborne contaminants.

The workstations, which are available in 61 cm and 81 cm-wide models, are the equivalent of Class 100 vertical laminar flow hoods with timed UV light.

Airborne contaminants are prevented from entering into the work zone through constant positive pressure HEPA filtered air. Each MY-PCR Prep Station is equipped with a built-in 254 nanometer shortwave lamp to effectively decontaminate the work area between amplifications. Safety interlocks are included on all PCR Prep Stations to prevent operator exposure to potentially harmful UV radiation.

The main chamber of MY-PCR Prep is constructed from a continuous piece of polycarbonate to prevent UV light from escaping the chamber during irradiation. Operator access is gained through the folding front polycarbonate sash, overlapped to eliminate gaps in the chamber during operation of the UV light. The work surface is white polypropylene that facilitates cleaning and disinfection.

The manufacturer reminds MY-PCR operators that the workstations are not biological safety cabinets. They are designed to provide process protection only from potential airborne contaminants found in the laboratory space.

Related Links:
Mystaire Misonix




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.